Discover the full insider trade history of Ocumension Therapeutics - B, a listed equity based in Hong Kong. Shares trade on HK HK, under the authority of HKEX. Operating in the Healthcare sector, Ocumension Therapeutics - B has logged 2 insider filings. Market capitalisation: €5.1bn. The latest transaction was disclosed on 1 April 2026 — Sale. Among the most active insiders: Hu Zhaopeng. All data is accessible without an account.